Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma.

Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma. Cancer. 2011 May 15; 117(10):2112-9.

View in: PubMed